PharmswellBio Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
21,433
20,672
18,874
15,719
19,593
Cost of Goods Sold (COGS) incl. D&A
17,381
16,808
15,724
12,731
14,745
Gross Income
4,052
3,864
3,150
2,987
4,847
SG&A Expense
3,220
4,454
3,053
6,048
4,287
Unusual Expense
43
8
132
22
175
Non Operating Income/Expense
143
238
116
262
875
Interest Expense
364
527
1,377
741
483
Pretax Income
141
728
846
3,721
346
Equity in Affiliates
-
71
2,724
423
-
Consolidated Net Income
151
217
3,570
4,145
346
Net Income
165
216
3,570
4,145
346
Net Income After Extraordinaries
165
1,184
2,059
4,145
346
Net Income Available to Common
165
1,616
9,199
4,145
346
EPS (Basic)
9.00
85.00
466.00
185.00
14.00
Basic Shares Outstanding
19
19
20
22
24
EPS (Diluted)
8.80
85.14
466.25
184.53
14.17
Diluted Shares Outstanding
19
19
20
22
24
EBITDA
780
466
241
2,984
687
Other Operating Expense
165
26
6
99
38
Non-Operating Interest Income
25
170
191
419
232
Minority Interest Expense
14
1
-
-
-
Equity in Affiliates (Pretax)
-
-
-
-
625
About PharmswellBio Co.
View Profile
